Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-familial primary hyperparathyroidism

G Akerström1

  • 1Department of Surgery, University Hospital, Uppsala, Sweden.

Seminars in Surgical Oncology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable p-glycoprotein immunoreactivity unrelated to cytotoxic drug-resistance in-vitro of human adrenocortical carcinoma.

International journal of oncology·2011
Same author

Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.

Gene therapy·2011
Same author

Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Stathmin as a marker for malignancy in pheochromocytomas.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2009
Same author

Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1.

Biochemical and biophysical research communications·2006
Same author

25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2005
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Primary hyperparathyroidism (pHPT) is a common endocrine disorder. While often presenting subtly today, pHPT management involves surgery for most, though some mild cases may be monitored.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Surgical Management

Background:

  • Primary hyperparathyroidism (pHPT) is increasingly diagnosed, often with milder symptoms than historically observed.
  • While historically associated with severe bone disease and renal stones, modern pHPT presents with slower progression and less obvious clinical manifestations.
  • Pathophysiological studies reveal disturbed parathyroid gland secretory regulation and growth, linked to impaired calcium-sensing receptor function, underlying hypercalcemia in pHPT.

Purpose of the Study:

  • To review the evolving clinical presentation and management of primary hyperparathyroidism.
  • To discuss the efficacy and outcomes of surgical intervention for pHPT.
  • To explore the underlying molecular mechanisms contributing to pHPT pathophysiology and clinical heterogeneity.

Related Experiment Videos

Main Methods:

  • Literature review of primary hyperparathyroidism epidemiology, clinical features, and management strategies.
  • Analysis of current understanding of pHPT pathophysiology, including parathyroid cell receptor function and growth regulation.
  • Discussion of surgical outcomes and considerations for non-operative management in select pHPT cases.

Main Results:

  • pHPT diagnosis has shifted towards less symptomatic presentations with slower disease progression.
  • Surgical treatment for pHPT is highly effective, reducing risks of metabolic and cardiovascular complications.
  • Some elderly patients with mild, asymptomatic pHPT may be safely managed non-operatively.

Conclusions:

  • Effective surgical options exist for primary hyperparathyroidism, improving patient outcomes.
  • Understanding the molecular basis of pHPT is crucial for explaining varied clinical presentations and disease progression.
  • Careful patient selection is necessary to determine optimal management, balancing surgical intervention with non-operative monitoring.